Clinical Trials in Boston

Showing 10821-10840 of 17,836 trials

Proton Radiotherapy for Stage I, IIA, and IIB Seminoma

NCT01557790

Phase II study using Proton radiation therapy to treat males, aged 18 years or older, with Stage I, IIA and IIB Seminoma. This research study will be done in conjunction with the Robert H. Burr Proton Therapy Center at the Mass. General Hospital and the Department of Defense. In the feasibility portion of the study patients will be evaluated to determine acute toxicity. If the study is deemed feasible the principal investigator (PI) hopes that proton RT will reduce the lethargy rate as compared to photon radiation therapy (RT).

Stage I, IIA and IIB Seminoma

Abramson Cancer Center at Penn Medicine5 participantsStarted Mar 2012

Boston, Massachusetts, United States • Philadelphia, Pennsylvania, United States

COMPLETEDNA< 1 mile

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

NCT01628159

The purpose of the study is to collect additional safety and efficacy information on the Lutonix (formerly Moxy) Drug Coated Balloon for treatment of stenosis or occlusion of the femoral and popliteal arteries.

Peripheral Artery Disease

C. R. Bard657 participantsStarted Jun 2012

Los Angeles, California, United States • Oceanside, California, United States • Orange, California, United States +61 more locations

Proton Radiotherapy for Stage I, IIA, and IIB Seminoma

LEVANT 2 Continuation Registry of the Lutonix® Drug Coated Balloon (DCB)

Find Trials by Condition in Boston

The Effect of Dexmedetomidine on Airway Complications After Deep or Awake Extubation

Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Ambulation as a Factor on Oscillating Thermometry

Deceased Donor Biomarkers and Recipient Outcomes

Intervention for Battered Sheltered Women With Substance Use Randomized Trial

Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis

Evaluation of a New Critical Pathway for Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA)

A Machine Learning Approach for Inferring Alcohol Intoxication Levels From Gait Data

Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II)

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

Moxetumomab Pasudotox for Advanced Hairy Cell Leukemia

Flavopiridol in Treating Patients With Metastatic Malignant Melanoma

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

Evaluation of Virtual Touch Tissue Imaging Quantification (VTIQ - 2D-SWE) in the Assessment of BI-RADS® 3 and 4 Lesions